No specific drug therapy for sarcopenia has been established; since inflammatory cytokines such as TNFα and IL-6 produce muscle atrophy, biological agents such as TNF and IL-6 inhibitors used to treat RA may improve sarcopenia in patients with RA, but the evidence is currently limited. The gene discussed is TNF; the disease is sarcopenia.